Preventing pneumothorax during transthoracic lung biopsy
Ended Project Grant Awarded Last action
- Award ID
- R43CA247832
- Recipient
-
Cambridge Polymer Group, Inc. UEI DKJDB8BKRGB3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $147,147
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $156,773.00 Federal
- -$9,626.00 Non-federal
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $9,626 | $0 | |
| Amendment | $9,626 | $0 | |
| Amendment | $9,626 | $0 | |
| Amendment | -$9,626 | $0 | |
| Amendment | -$9,626 | -$9,626 | |
| Original award | $147,147 | $0 |
Quick answers
Who received award R43CA247832?
R43CA247832 was awarded to Cambridge Polymer Group, Inc. by National Cancer Institute (National Institutes of Health) on September 18, 2019.
How much is award R43CA247832 worth?
$147,147 has been obligated on R43CA247832: $156,773 in federal funding and -$9,626 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award